KLF9 and familial dilated cardiomyopathy: Second, we found that KLF9 acted as a cardiac-deteriorating effector during DCM, since when we manipulated the expression level of KLF9, DCM progression was suppressed with low levels of KLF9 but exacerbated with high levels of KLF9.